← Back to headlines

CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia

This story is reported by News-Medical. Read what other outlets are saying below, then open the original report for full details.

CIRM awards $7.4 million to advance stem cell-based gene therapy for Friedreich's ataxia · NabkaNews